Skip to main content
Top
Published in: Malaria Journal 1/2014

Open Access 01-09-2014 | Poster presentation

Vector control using LLIN/ITN: reduction of malaria morbidity in Bangladesh

Authors: Mohammad Moktadir Kabir, Shamsun Naher, Akramul Islam, Abdul Karim, Mohammad Harun-Or Rasid, Shahidul Islam Laskar

Published in: Malaria Journal | Special Issue 1/2014

Login to get access

Excerpt

Malaria is one of the major public health concerns due to re-emergence of the disease in Bangladesh in the 1990s. Currently it is endemic in 13 out of 64 administrative districts bordering India and Myanmar. Three hill tract districts (Khagrachhari, Rangmati, Bandarban) in the south-eastern part of the country report the highest incidences. The overall prevalence rate is 3.1% in the 13 endemic districts and 11% in 3 hill districts. …
Metadata
Title
Vector control using LLIN/ITN: reduction of malaria morbidity in Bangladesh
Authors
Mohammad Moktadir Kabir
Shamsun Naher
Akramul Islam
Abdul Karim
Mohammad Harun-Or Rasid
Shahidul Islam Laskar
Publication date
01-09-2014
Publisher
BioMed Central
Published in
Malaria Journal / Issue Special Issue 1/2014
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-13-S1-P47

Other articles of this Special Issue 1/2014

Malaria Journal 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.